Citius Pharmaceuticals, Inc.
Viés de alta

$CTXR Bullish Pitchfork & Divergence after strong 8-k

Oversold conditions with bullish divergence signals on the loom after a strong 8-k with optimistic outlooks on Mino-Lok and COVID/ARDS treatment

Aviso legal